Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children

Publication date: Available online 19 February 2021Source: International Journal of Pediatrics and Adolescent MedicineAuthor(s): Jan Beute, Alex KleinJan

Source: International Journal of Pediatrics and Adolescent Medicine - February 20, 2021 Category: Pediatrics Source Type: research